William Blair & Company
CMD

William Blair & Company’s Cantel Medical Corporation CMD Stock Holding History

William Blair & Company’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,937
Closed -$234K – 1956
2021
Q1 		$234K Hold
2,937
– – ﹤0.01% 1424
2020
Q4 		$232K Buy
+2,937
New +$172K ﹤0.01% 1368
2019
Q3 		– Sell
-2,312
Closed -$225K – 1783
2019
Q2 		$225K Sell
2,312
-50
-2% -$3.52K ﹤0.01% 1263
2019
Q1 		$230K Sell
2,362
-250
-10% -$18.9K ﹤0.01% 1250
2018
Q4 		$254K Hold
2,612
– – ﹤0.01% 1144
2018
Q3 		$240K Sell
2,612
-220
-8% -$21K ﹤0.01% 1225
2018
Q2 		$279K Sell
2,832
-453
-14% -$50.7K ﹤0.01% 1155
2018
Q1 		$366K Sell
3,285
-600
-15% -$67.2K ﹤0.01% 1018
2017
Q4 		$400K Hold
3,885
– – ﹤0.01% 1039
2017
Q3 		$366K Hold
3,885
– – ﹤0.01% 1040
2017
Q2 		$303K Buy
+3,885
New +$292K ﹤0.01% 1184

William Blair & Company's CMD Position: Q2 2021 in Review

William Blair & Company sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 2,937 shares — an estimated $234K sold.

William Blair & Company first reported a position in CMD in Q2 2017 and held it in 11 quarters. The position peaked at $400K in Q4 2017. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • William Blair & Company reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • William Blair & Company sold 2,937 Cantel Medical Corporation shares in Q2 2021, an estimated $234K.
  • William Blair & Company first reported a position in Cantel Medical Corporation in Q2 2017 and held it in 11 quarters.
  • William Blair & Company's Cantel Medical Corporation position peaked at $400K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on William Blair & Company's 13F filing for Q2 2021, filed 12 Aug 2021.